Varicella Vaccine, Live

Launched in 2020

lThe only new-generation varicella vaccine backed by evidence in phase III clinical efficacy results


lProtective efficacy of 89.2% against breakthrough cases, and 100% against moderate and severe cases


lSafer viral release enabled by physical technology, and formulation optimized to reduce pain


lWHO prequalified vaccine


Related news
year:
--ALL--
  • --ALL--
Load More
© SINOVAC